Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Aug 05, 2021 7:36pm
RE:Why I'm invested in IPA...
Give it a listen!! Very sobering and certainly aligns with Jennifers early predictions and stance. She/IPA, could be in for a Nobel Prize next December. Not out of the question at all.
(742)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Aug 05, 2021 5:17pm
Why I'm invested in IPA...
https://www.forbes.com/sites/williamhaseltine/2021/08/04/a-warning-about-the-future-of-covid-19-from-the-scientific-advisory-group-for-emergencies-of-the-united-kingdom/?sh=48b416f2e54f This is a
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Aug 04, 2021 2:20pm
Remember.
19.8 million shares out there in circulation is ridiculously miniscule. Avg, Nasdaq stock has 200 million shares outstanding, some have 500 million o/s. This could close today at $8.00....open
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Aug 02, 2021 2:10pm
What's coming down the pipeline?
These have strongly been hinted to be in the pipeline. Some would occur by summers end. 1- Partnership with Pharma or Foundation 2- Coverage by a US bank or Major Institution 3- NDA
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Jul 30, 2021 2:09pm
Just read "Over 100 countries with major Delta outbreaks!"
We are all going to be wearing masks again. IPAs cocktail looks so good I had to buy back in. There must be at least one Pharma or Foundation wanting to be the first to own this therapy. Or at least
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Comment by
wallpaper2
on Jul 29, 2021 8:11pm
RE:Since Last Thursday
CIBC may have purchased that many shares but they appear to have sold just as many or more (algo trading.) I agree with Dart when he says the recent run up looked orchestrated, to allow institutions
...more
(15)
•••
Stocks2Go
X
View Profile
View Bullboard History
Post by
Stocks2Go
on Jul 29, 2021 4:21pm
Since Last Thursday
8.7 million shares traded. High was $20.21 / share. CIBC purchased 3.3 million at $13.66. Average price for the 8.7 million traded was $12.61 Last private placement was a bought deal of $21 million at
...more
(80)
•••
bingostar
X
View Profile
View Bullboard History
Comment by
bingostar
on Jul 29, 2021 11:02am
RE:RE:RE:Stock manipulation
I told you
(9)
•••
dave17
X
View Profile
View Bullboard History
Post by
dave17
on Jul 28, 2021 2:21pm
Check out $Zomd 96% growth very undervalued
https://finance.yahoo.com/news/zoomd-announces-preliminary-2q2021-financial-133000457.html
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Jul 28, 2021 2:19pm
CIBC selling heavily every day.
???
(2377)
•••
dart321
X
View Profile
View Bullboard History
Comment by
dart321
on Jul 28, 2021 12:48pm
RE:Contract Research Org. versus Internal Research
To me it looked like this last pump was to get certain institutions that where stuck in this stock, out. Now it will likely drift back to where it should be which is 2 times sales plus cash on hand or
...more
(157)
•••
cleareye
X
View Profile
View Bullboard History
Post by
cleareye
on Jul 28, 2021 8:42am
Contract Research Org. versus Internal Research
I continue to be curious of the business model of being a CRO (contract research organization) vs. the ongoing internal research. I am not sure you can do both. Internal "bamboo curtains"
...more
(157)
•••
cleareye
X
View Profile
View Bullboard History
Post by
cleareye
on Jul 28, 2021 8:38am
News Release and YE Financials Released.
Here's a few highlights: Earned revenues of $17.9 million, a 27% increase which includes a sale through Talem of an internally generated therapeutic antibody for $1.2 million, core CRO
...more
(15)
•••
Stocks2Go
X
View Profile
View Bullboard History
Comment by
Stocks2Go
on Jul 26, 2021 12:12pm
RE:RE:Wall Street bets picking up IPA
Even $50 would be great. Such a low float. Only 19 million shares
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.